uniQure N.V.
Developing AAV-based gene therapies for rare liver and central nervous system disorders.
QURE | US
Overview
Corporate Details
- ISIN(s):
- NL0010696654
- LEI:
- Country:
- United States of America
- Address:
- PAASHEUVELWEG 25A, AMSTERDAM
- Website:
- https://www.uniqure.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
uniQure N.V. is a pioneering gene therapy company dedicated to developing transformative treatments for patients with rare and severe diseases. Leveraging more than two decades of innovation, the company utilizes its proprietary AAV-based technology platform to create single-administration, potentially curative therapies. uniQure's research and development efforts are focused on a pipeline of programs targeting liver-directed and central nervous system (CNS) disorders, including Huntington's disease and hemophilia. The company's mission is to translate leading-edge science into innovative cures that transform patients' lives, supported by proven manufacturing capabilities.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all uniQure N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for uniQure N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for uniQure N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
%20LTD/other/Cuprina_Holdings_Cayman_LTD-logo.png){kind=logo}
